Bethesda Hospital

'Listen to your patients for early identification of Peripheral Neuropathy' say leading Health Experts at P&G's #KNOWTHESIGNS Scientific Forum

Retrieved on: 
Monday, November 6, 2023
Global Medical Device Nomenclature, Patient, Ulcer, Education, PN, Prickle (protein), Neuropathic pain, Neurology, Assistant, Facial muscles, Physician, Prevalence, IDF, Burning Sensations, Health, International Diabetes Federation, DPN, Type 2 diabetes, WDD, Finger, Foot, Hypoesthesia, Senior, AMA, Prediabetes, Paresthesia, Quality of life, Bethesda Hospital, The, Extremities, Risk, P&G, Peripheral neuropathy, Lyceum, Trial of the century, B, Pharmacist, Ankle, Amputation, Diagnosis, Consultant, Infection, Dietary supplement, Pharmaceutical industry, Diabetes

The signature event saw deliberations on the latest clinical guidance on diagnoses and treatment of Peripheral Neuropathy (PN) in Diabetes and Pre-Diabetes.

Key Points: 
  • The signature event saw deliberations on the latest clinical guidance on diagnoses and treatment of Peripheral Neuropathy (PN) in Diabetes and Pre-Diabetes.
  • With Diabetes Mellitus Type 2 being the leading cause of PN, its increasing prevalence is closely linked to the rise in the number of diabetics.
  • B vitamin deficiency and polymedication are other high-risk factors along with diabetes, leading to peripheral nerve damage.
  • Patients should be educated about the importance of regular foot and DPN examinations, glycemic control, and adherence to prescribed medications.

Aspira Women’s Health Hosting Women’s Health Webinar on Ovarian Cancer Risk Assessments Utilizing Multivariant Index Assay

Retrieved on: 
Thursday, August 18, 2022
Endometriosis, CEO, GLOBE, FACS, FACOG, Eastern Time Zone, Annual report, Bethesda Hospital, Patient, Detection, KOL, MD, Health, Risk, Private Securities Litigation Reform Act, Congress, Life, Innovation, OB, Gynaecology, Doctor of Philosophy, Physician, Ovarian cancer, Art in the US Women's Suffrage Movement, Bethesda, GYN, Solution, JCO, FDA, Woman, Biomarker, Genetic testing, Steven Naifeh, Risk assessment, University, Medicine, Birth control, Medical device, Mensa International, Aspira

AUSTIN, Texas, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Aspira Womens Health Inc. (Aspira), a bio-analytical based womens health company focused on gynecologic disease, today announced that it will host a key opinion leader (KOL) webinar on womens health and ovarian cancer risk assessments utilizing multivariant index assays on Wednesday, August 24, 2022 at 12:00pm Eastern Time.

Key Points: 
  • AUSTIN, Texas, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Aspira Womens Health Inc. (Aspira), a bio-analytical based womens health company focused on gynecologic disease, today announced that it will host a key opinion leader (KOL) webinar on womens health and ovarian cancer risk assessments utilizing multivariant index assays on Wednesday, August 24, 2022 at 12:00pm Eastern Time.
  • He will discuss how Aspiras soon-to-be-launched OVAWatchTM multivariate index assay diagnostic risk assessment may benefit women with pelvic masses who are not planned for surgery.
  • About Aspira Womens Health Inc.
    Aspira Womens Health Inc. is transforming womens health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management, and improve gynecologic health outcomes for women.
  • Aspira Womens Health is particularly focused on closing the ethnic disparity gap in ovarian cancer risk assessment and developing solutions for pelvic diseases such as pelvic mass risk assessment and endometriosis.

FAU HEALTH NETWORK QUICKLY ADDS MORE PARTNERS

Retrieved on: 
Monday, June 20, 2022
Memorial Hermann Health System, Population, Florida Atlantic University, Cleveland Clinic, Working poor, Charles E. Schmidt College of Medicine, Partner, Achievement, Foundation (nonprofit), CEO, News, Nursing, Baptist Health, Nick Caserio, Research, Bethesda Hospital, Medical Affairs Bureau, Carnegie Foundation, Palm Beach Atlantic University, Physician, BOCA, U.S. News & World Report, Boca Raton Regional Hospital, University, Volunteering, Carnegie Foundation for the Advancement of Teaching, Caridad, Workforce, Partnership, Palm Beach State College, Health, Tenet Healthcare, FAU, Patient, Broward College, Education, Social, Broward Health, Hospital, Medicine

"The FAU Health Network -- a true collaboration that brings together the region's already robust health care infrastructure -- will help save lives and cure diseases," said Julie Pilitsis, M.D., Ph.D., dean and vice president for medical affairs, Florida Atlantic University's Schmidt College of Medicine. "Collectively, we are stronger. Together, we will help make our community an even greater place than it is today."

Key Points: 
  • "The FAU Health Network -- a true collaboration that brings together the region's already robust health care infrastructure -- will help save lives and cure diseases," said Julie Pilitsis , M.D., Ph.D., dean and vice president for medical affairs, Florida Atlantic University 's Schmidt College of Medicine .
  • "Our hospital already collaborates with FAU and other area health care providers," said Lincoln Mendez, CEO of Boca Raton Regional Hospital.
  • Further, the FAU Health Network will foster a true sense of community, from the well-being of the region's front-line workforce to the quality of service delivered to patients from all walks of life.
  • Partners previously announced include: Broward College , Palm Beach State College , Memorial Healthcare System , Health Care District of Palm Beach County and Broward Health .